Management of regional citrate anticoagulation for continuous renal replacement therapy : guideline recommendations from Chinese emergency medical doctor consensus
© 2023. The Author(s)..
Continuous renal replacement therapy (CRRT) is widely used for treating critically-ill patients in the emergency department in China. Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT. Regional citrate anticoagulation (RCA) has been shown to potentially be safer and more effective and is now recommended as the preferred anticoagulant method for CRRT. However, there is still a lack of unified standards for RCA management in the world, and there are many problems in using this method in clinical practice. The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association (CMDA) organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues, including the advantages and disadvantages of RCA in CRRT anticoagulation, the principle of RCA, parameter settings for RCA, monitoring of RCA (mainly metabolic acid-base disorders), and special issues during RCA. Based on the latest available research evidence as well as the paneled experts' clinical experience, considering the generalizability, suitability, and potential resource utilization, while also balancing clinical advantages and disadvantages, a total of 16 guideline recommendations were formed from the experts' consensus.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Military Medical Research - 10(2023), 1 vom: 29. Mai, Seite 23 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Shu-Yuan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticoagulants |
|---|
| Anmerkungen: |
Date Completed 31.05.2023 Date Revised 08.06.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s40779-023-00457-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357506898 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357506898 | ||
| 003 | DE-627 | ||
| 005 | 20231226072736.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40779-023-00457-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1191.xml |
| 035 | |a (DE-627)NLM357506898 | ||
| 035 | |a (NLM)37248514 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Shu-Yuan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of regional citrate anticoagulation for continuous renal replacement therapy |b guideline recommendations from Chinese emergency medical doctor consensus |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.05.2023 | ||
| 500 | |a Date Revised 08.06.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a Continuous renal replacement therapy (CRRT) is widely used for treating critically-ill patients in the emergency department in China. Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT. Regional citrate anticoagulation (RCA) has been shown to potentially be safer and more effective and is now recommended as the preferred anticoagulant method for CRRT. However, there is still a lack of unified standards for RCA management in the world, and there are many problems in using this method in clinical practice. The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association (CMDA) organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues, including the advantages and disadvantages of RCA in CRRT anticoagulation, the principle of RCA, parameter settings for RCA, monitoring of RCA (mainly metabolic acid-base disorders), and special issues during RCA. Based on the latest available research evidence as well as the paneled experts' clinical experience, considering the generalizability, suitability, and potential resource utilization, while also balancing clinical advantages and disadvantages, a total of 16 guideline recommendations were formed from the experts' consensus | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anticoagulation | |
| 650 | 4 | |a Citrate | |
| 650 | 4 | |a Continuous renal replacement therapy | |
| 650 | 4 | |a Emergency | |
| 650 | 4 | |a Expert consensus | |
| 650 | 4 | |a Guideline | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Citrates |2 NLM | |
| 700 | 1 | |a Xu, Sheng-Yong |e verfasserin |4 aut | |
| 700 | 1 | |a Yin, Lu |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Kui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Qiu-Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Ding-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Xin, Tian-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yu-Guo |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Xiao-Dong |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Xue-Zhong |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jun |e verfasserin |4 aut | |
| 700 | 0 | |a Emergency Medical Doctor Branch of the Chinese Medical Doctor Association |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xu-Feng |e investigator |4 oth | |
| 700 | 1 | |a Chen, Zhi |e investigator |4 oth | |
| 700 | 1 | |a Dou, Qing-Li |e investigator |4 oth | |
| 700 | 1 | |a Guan, Jian |e investigator |4 oth | |
| 700 | 1 | |a Gui, Yao-Song |e investigator |4 oth | |
| 700 | 1 | |a Huang, Zhong-Wei |e investigator |4 oth | |
| 700 | 1 | |a Li, Xiao-Min |e investigator |4 oth | |
| 700 | 1 | |a Liu, Dan-Ping |e investigator |4 oth | |
| 700 | 1 | |a Lv, Jing-Jun |e investigator |4 oth | |
| 700 | 1 | |a Liu, Yong |e investigator |4 oth | |
| 700 | 1 | |a Qian, Chuan-Yun |e investigator |4 oth | |
| 700 | 1 | |a Shan, Yi |e investigator |4 oth | |
| 700 | 1 | |a Shi, Yan |e investigator |4 oth | |
| 700 | 1 | |a Sun, Ming |e investigator |4 oth | |
| 700 | 1 | |a Wu, Hai-Ying |e investigator |4 oth | |
| 700 | 1 | |a Xia, Jian |e investigator |4 oth | |
| 700 | 1 | |a Xu, Feng |e investigator |4 oth | |
| 700 | 1 | |a Xu, Tie |e investigator |4 oth | |
| 700 | 1 | |a Yan, Xian-Liang |e investigator |4 oth | |
| 700 | 1 | |a Yang, Jian-Zhong |e investigator |4 oth | |
| 700 | 1 | |a Yu, Yong-Wu |e investigator |4 oth | |
| 700 | 1 | |a Zhang, Jin-Song |e investigator |4 oth | |
| 700 | 1 | |a Zhang, Mao |e investigator |4 oth | |
| 700 | 1 | |a Zhang, Wei |e investigator |4 oth | |
| 700 | 1 | |a Zhao, Hong-Yu |e investigator |4 oth | |
| 700 | 1 | |a Zheng, Dong-Hui |e investigator |4 oth | |
| 700 | 1 | |a Zhou, Ping |e investigator |4 oth | |
| 700 | 1 | |a Zhu, Bao-Feng |e investigator |4 oth | |
| 700 | 1 | |a Zhu, Hua-Dong |e investigator |4 oth | |
| 700 | 1 | |a Shen, Shi-Qian |e investigator |4 oth | |
| 700 | 1 | |a Prowle, John |e investigator |4 oth | |
| 700 | 1 | |a Bellgardt, Martin |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Military Medical Research |d 2014 |g 10(2023), 1 vom: 29. Mai, Seite 23 |w (DE-627)NLM246615990 |x 2054-9369 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:1 |g day:29 |g month:05 |g pages:23 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s40779-023-00457-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 1 |b 29 |c 05 |h 23 | ||